{"name":"Pfizer","permalink":"pfizer","crunchbase_url":"http://www.crunchbase.com/company/pfizer","homepage_url":"http://www.pfizer.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":null,"alias_list":"","email_address":"","phone_number":"212-573-2323","description":"","created_at":"Wed Dec 10 21:04:20 UTC 2008","updated_at":"Thu Aug 09 03:24:04 UTC 2012","overview":"<p>Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company applies science and its global resources to improve health and well-being at every stage of life. Pfizerâ€™s diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many consumer health care products. The Company operates in two business segments: Biopharmaceutical and Diversified. Biopharmaceutical includes the Primary Care, Specialty Care, Established Products, Emerging Markets and Oncology customer-focused units. Diversified includes Animal Health products that prevent and treat diseases in livestock and companion animals, and Consumer Healthcare products. On October 15, 2009, the Company completed its acquisition of Wyeth. In December 2009, Durata Therapeutics, Inc. acquired Vicuron Pharmaceuticals from Pfizer. </p>","image":{"available_sizes":[[[82,55],"assets/images/resized/0005/9046/59046v1-max-150x150.png"],[[82,55],"assets/images/resized/0005/9046/59046v1-max-250x250.png"],[[82,55],"assets/images/resized/0005/9046/59046v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Chairman & CEO","person":{"first_name":"Ian","last_name":"Read","permalink":"ian-read","image":null}},{"is_past":false,"title":"EVP, CFO & Business Operations","person":{"first_name":"Frank","last_name":"A. D'Amelio","permalink":"frank-a-damelio","image":null}},{"is_past":true,"title":"CEO","person":{"first_name":"Jeffrey","last_name":"B. Kindler","permalink":"jeffrey-b-kindler","image":null}}],"competitions":[],"providerships":[{"title":"SEO","is_past":true,"provider":{"name":"Search Mojo","permalink":"search-mojo","image":{"available_sizes":[[[150,31],"assets/images/resized/0003/1496/31496v2-max-150x150.jpg"],[[189,40],"assets/images/resized/0003/1496/31496v2-max-250x250.jpg"],[[189,40],"assets/images/resized/0003/1496/31496v2-max-450x450.jpg"]],"attribution":null}}},{"title":"","is_past":true,"provider":{"name":"PerformanceG2","permalink":"performanceg2","image":{"available_sizes":[[[150,21],"assets/images/resized/0004/5570/45570v2-max-150x150.jpg"],[[250,35],"assets/images/resized/0004/5570/45570v2-max-250x250.jpg"],[[280,40],"assets/images/resized/0004/5570/45570v2-max-450x450.jpg"]],"attribution":null}}}],"total_money_raised":"$0","funding_rounds":[],"investments":[{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/aureon-laboratories-series-d-7m/","source_description":"","raised_amount":7000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":14,"company":{"name":"Aureon Laboratories","permalink":"aureon-laboratories","image":{"available_sizes":[[[150,37],"assets/images/resized/0008/4867/84867v1-max-150x150.jpg"],[[250,62],"assets/images/resized/0008/4867/84867v1-max-250x250.jpg"],[[289,72],"assets/images/resized/0008/4867/84867v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.merus.nl/news/10/16/Merus-closes-EUR-21-7-million-Series-B-financing-and-enters-option-agreement-with-the-Novartis-Option-Fund.html","source_description":"Merus closes EUR 21.7 million Series B financing and enters option agreement with the Novartis Option Fund","raised_amount":21700000,"raised_currency_code":"EUR","funded_year":2010,"funded_month":1,"funded_day":29,"company":{"name":"Merus","permalink":"merus","image":{"available_sizes":[[[150,57],"assets/images/resized/0007/5586/75586v1-max-150x150.jpg"],[[164,63],"assets/images/resized/0007/5586/75586v1-max-250x250.jpg"],[[164,63],"assets/images/resized/0007/5586/75586v1-max-450x450.jpg"]],"attribution":null}}}}],"acquisition":null,"acquisitions":[{"price_amount":195000000,"price_currency_code":"USD","term_code":"cash","source_url":"http://www.marketwatch.com/story/pfizer-to-buy-encysive-for-195-million","source_description":"Pfizer to buy Encysive for $195 million","acquired_year":2008,"acquired_month":2,"acquired_day":20,"company":{"name":"Encysive Pharmaceuticals","permalink":"encysive-pharmaceuticals","image":null}},{"price_amount":null,"price_currency_code":"USD","term_code":null,"source_url":"http://www.foldrx.com/e4df4c77-5824-4ea5-94b7-aede5d74e4f5/news-press-detail.htm","source_description":"Pfizer To Acquire FoldRx Pharmaceuticals","acquired_year":2010,"acquired_month":9,"acquired_day":1,"company":{"name":"Foldrx Pharmaceuticals","permalink":"foldrx-pharmaceuticals","image":null}},{"price_amount":3600000000,"price_currency_code":"USD","term_code":"cash","source_url":"http://www.fiercebiotech.com/story/pfizer-embraces-pain-pipeline-3-6b-king-buyout/2010-10-12?utm_medium=rss&utm_source=rss","source_description":"Pfizer takes King in $3.6B pain gambit","acquired_year":2010,"acquired_month":10,"acquired_day":12,"company":{"name":"King Pharmaceuticals","permalink":"king-pharmaceuticals","image":{"available_sizes":[[[150,52],"assets/images/resized/0010/0798/100798v1-max-150x150.png"],[[250,87],"assets/images/resized/0010/0798/100798v1-max-250x250.png"],[[275,96],"assets/images/resized/0010/0798/100798v1-max-450x450.png"]],"attribution":null}}},{"price_amount":56000000,"price_currency_code":"USD","term_code":null,"source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32&aid=DJFVW00020111028e7asywmog&r=Rss&s=DJFVW","source_description":"\t  Pfizer Acquires Icagen, Ends Fight By Two Venture Investors","acquired_year":2011,"acquired_month":10,"acquired_day":28,"company":{"name":"ICAgen","permalink":"icagen","image":{"available_sizes":[[[143,98],"assets/images/resized/0006/1129/61129v1-max-150x150.jpg"],[[143,98],"assets/images/resized/0006/1129/61129v1-max-250x250.jpg"],[[143,98],"assets/images/resized/0006/1129/61129v1-max-450x450.jpg"]],"attribution":null}}},{"price_amount":null,"price_currency_code":"USD","term_code":null,"source_url":"http://articles.marketwatch.com/2012-10-22/industries/34636823_1_nextwave-shareholders-pfizer-private-firm","source_description":"Pfizer buying private NextWave for up to $680 mln","acquired_year":2012,"acquired_month":10,"acquired_day":22,"company":{"name":"NextWave Pharmaceuticals","permalink":"nextwave-pharmaceuticals","image":{"available_sizes":[[[150,89],"assets/images/resized/0011/6922/116922v1-max-150x150.jpg"],[[217,130],"assets/images/resized/0011/6922/116922v1-max-250x250.jpg"],[[217,130],"assets/images/resized/0011/6922/116922v1-max-450x450.jpg"]],"attribution":null}}}],"offices":[{"description":"","address1":"235 East 42nd Street","address2":"","zip_code":"10017","city":"New York","state_code":"NY","country_code":"USA","latitude":null,"longitude":null}],"milestones":[{"description":"Pfizer ends brain cancer vaccine deal with Celldex","stoned_year":2010,"stoned_month":9,"stoned_day":3,"source_url":"http://www.masshightech.com/stories/2010/08/30/daily65-Pfizer-ends-brain-cancer-vaccine-deal-with-Celldex-.html","source_text":null,"source_description":"Pfizer ends brain cancer vaccine deal with Celldex","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Pfizer","permalink":"pfizer"}},{"description":"has established a new network of academic centers that will serve as a â€œfarm teamâ€ for drug development.","stoned_year":2010,"stoned_month":11,"stoned_day":16,"source_url":"http://www.masshightech.com/stories/2010/11/15/daily17-New-Pfizer-academic-industrial-program-based-in-Cambridge.html","source_text":null,"source_description":"New Pfizer academic-industrial program based in Cambridge","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Pfizer","permalink":"pfizer"}},{"description":"Pfizer ups ante on Santaris RNA discovery deal with $614M pact\r\n","stoned_year":2011,"stoned_month":1,"stoned_day":4,"source_url":"http://www.fiercebiotech.com/story/pfizer-ups-ante-santaris-rna-discovery-deal-614m-pact/2011-01-04?utm_medium=rss&utm_source=rss","source_text":"","source_description":"Pfizer ups ante on Santaris RNA discovery deal with $614M pact ","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Pfizer","permalink":"pfizer"}}],"ipo":{"valuation_amount":null,"valuation_currency_code":"USD","pub_year":null,"pub_month":null,"pub_day":null,"stock_symbol":"NYSE:PFE"},"video_embeds":[],"screenshots":[],"external_links":[]}